202 related articles for article (PubMed ID: 6377685)
21. Fatty acid oxidation inhibition with PPARalpha activation (FOXIB/PPARalpha) for normalizing gene expression in heart failure?
Rupp H; Rupp TP; Maisch B
Cardiovasc Res; 2005 Jun; 66(3):423-6. PubMed ID: 15914105
[No Abstract] [Full Text] [Related]
22. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Thupari JN; Pinn ML; Kuhajda FP
Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
[TBL] [Abstract][Full Text] [Related]
23. 4-Bromocrotonic acid, an effective inhibitor of fatty acid oxidation and ketone body degradation in rat heart mitochondria. On the rate-determining step of beta-oxidation and ketone body degradation in heart.
Olowe Y; Schulz H
J Biol Chem; 1982 May; 257(10):5408-13. PubMed ID: 7068598
[TBL] [Abstract][Full Text] [Related]
24. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
Vickers AE; Bentley P; Fisher RL
Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
[TBL] [Abstract][Full Text] [Related]
25. Increased hepatic fatty-acid oxidation in clofibrate-treated rats [proceedings].
Thomas J; Debeer LJ; Mannaerts GP
Arch Int Physiol Biochim; 1978 May; 86(2):459-61. PubMed ID: 81030
[No Abstract] [Full Text] [Related]
26. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
[TBL] [Abstract][Full Text] [Related]
27. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analyses of control exerted by overt carnitine palmitoyltransferase over hepatic fatty acid oxidation and ketogenesis in suckling rats.
Krauss S; Zammit VA; Quant PA
Biochem Soc Trans; 1996 Feb; 24(1):39S. PubMed ID: 8674708
[No Abstract] [Full Text] [Related]
29. [Studies on the regulation of carbohydrate metabolism in vivo. 3. Influence of the inhibition of fatty acid oxidation].
Nordmann R; Nordmann J
Biochimie; 1971; 53(5):705-8. PubMed ID: 4330859
[No Abstract] [Full Text] [Related]
30. Some aspects of fatty acid oxidation and ketone body formation and utilization during development of the rat.
Bailey E; Lockwood EA
Enzyme; 1973; 15(1):239-53. PubMed ID: 4593961
[No Abstract] [Full Text] [Related]
31. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
32. Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
Abdel-aleem S; Sharwi S; Badr M; Sayed-Ahmed M; Anstadt MP; Lowe JE
Horm Metab Res; 1995 Feb; 27(2):104-6. PubMed ID: 7759056
[No Abstract] [Full Text] [Related]
33. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
Sorokina N; O'Donnell JM; McKinney RD; Pound KM; Woldegiorgis G; LaNoue KF; Ballal K; Taegtmeyer H; Buttrick PM; Lewandowski ED
Circulation; 2007 Apr; 115(15):2033-41. PubMed ID: 17404155
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production.
Obici S; Feng Z; Arduini A; Conti R; Rossetti L
Nat Med; 2003 Jun; 9(6):756-61. PubMed ID: 12754501
[TBL] [Abstract][Full Text] [Related]
35. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
36. [On the mechanism of increased ketogenesis. II. Redox status of DPN in isolated rat liver during perfusion with fatty acids].
Löffler G; Matschinsky F; Wieland O
Biochem Z; 1965 Jun; 342(1):76-84. PubMed ID: 4284932
[No Abstract] [Full Text] [Related]
37. Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepatocytes and in vivo.
Hertz R; Bar-Tana J
Biochem J; 1987 Jul; 245(2):387-92. PubMed ID: 3663164
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802) (preliminary communication).
Tutwiler GF; Ryzlak MT
Life Sci; 1980 Feb; 26(5):393-7. PubMed ID: 7366330
[No Abstract] [Full Text] [Related]
39. The regulation of the release of ketone bodies by the liver.
Krebs HA
Adv Enzyme Regul; 1966; 4():339-54. PubMed ID: 4865971
[No Abstract] [Full Text] [Related]
40. Effects of C-methylated carnitine analogs on rates of mitochondrial fatty acid oxidation.
Brouillette WJ; Puckett SW; Comber RN; Hosmer CA
Biochem Pharmacol; 1993 Nov; 46(9):1671-3. PubMed ID: 8240425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
